Certara Announces 2026 Certainty Event
Certainty 2026: Explore AI-driven drug development and technological innovation at the leading biosimulation event for…
CertaraMarch 9, 2026
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…
CertaraFebruary 26, 2026
Ready for ESG NextGen, or still submitting like it’s 2015?
Learn how to prepare for ESG NextGen with automated, compliant submission workflows. Watch the webinar…
CertaraFebruary 5, 2026
The data fragmentation problem holding drug discovery back
Explore how fragmented data across the drug discovery DMTA cycle impedes progress, and discover how…
CertaraJanuary 21, 2026
Safety First: Uncovering the Clinical Risks Inside Your Compound Screening Data
Learn how to interpret screening assay data to predict clinical off-target risk with ToxStudio® and…
CertaraJanuary 13, 2026
Add Off-target Risk Profiling to Your Analyses
Certara's cheminformatics solution, D360, supports a key feature of Secondary Intelligence: a low-medium-high ranking of…
CertaraJanuary 5, 2026
